Osteoporosis can be a devastating diagnosis that causes seniors to seek home therapy because they have difficulty moving around on their own. However, scientists have been hard at work trying to help the millions of Americans who suffer from the bone disease.
Research out of the University of California, San Francisco, was conducted on the use of alendronate, part of the bisphosphonate family, which is a class of drugs that prevent loss of bone mass. The study's authors argue that even if people have therapy, they are still at risk for additional spinal fractures. However, if people continue taking alendronate, their chances of spinal fractures could decrease.
However, the Food and Drug Administration has been keeping an eye on some of the side effects that come with taking the drug for more than five years, such as atypical femur fractures. However, the study's authors say that the benefits could outweigh the risks.
"Each patient and her physician need to weigh the benefits versus the risks, but the purpose of our analysis was to try to give people a sense of what the benefits might be and in whom they would be highest," said Dr. Dennis Black, professor and division chief of UCSF’s Department of Epidemiology and Biostatistics’ Clinical Trials and Multicenter Studies.
Residential Home Health is a leading provider of in-home nursing and therapy care throughout Michigan and Illinois. In addition to home health care, Residential’s continuum of care includes Residential Hospice and Healthy Living Medical Supply. If you are interested in learning more about the home care services Residential provides, please call 866-902-4000 or visit www.residentialhomehealth.com.